XR5000 topoisomerase I/II inhibitor: XNVAY suspended a Phase II trial

Phase I 120-hour trials will conclude soon, and the

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE